Clinical SCORE introduces ATTUNE™ Analytics

Monday, October 31, 2016 Research News J E 4

CHADDS FORD, Pa., Oct. 31, 2016 /PRNewswire/ -- Clinical SCORE introduces a new service to help you optimize your clinical operations partnerships. ATTUNE™ Analytics provides real-time, quantitative anonymous site feedback that enables sponsors and contract research organizations (CROs) to strengthen collaborative relationships through actionable information.

"ATTUNE Analytics is a valuable tool for bringing sponsor/CRO relationships in sync and ensuring that goals are aligned," said Ross Weaver, managing director. "It is valuable both for immediate, practical problem solving and for long-term strategic decision making."

For example, when Asia Pacific sites stopped enrolling patients in a trial, ATTUNE revealed a payment problem. A vendor working with a specific CRO was delaying reimbursement to the APAC sites. Once the issue was identified, it was addressed with the vendor and resolved.

In another example, when enrollment was slow at study sites in Romania and Hungary, ATTUNE identified a training problem. The CRO was using trainers from the Czech Republic, resulting in language and cultural barriers. Confused, site staff slowed enrollment to avoid protocol deviations. Based on insights from ATTUNE, the CRO hired local trainers to get trial enrollment back on track.

ATTUNE Analytics collates site-specific feedback across trials, geographies, therapeutic areas, programs and partnerships. It reveals strengths and weaknesses across all relationships, including CROs, study suppliers, hardware and software systems. It identifies broad areas of concern and isolates specific, actionable issues. ATTUNE Analytics data is quantitative and blinded and, therefore, not anecdotal or biased. ATTUNE Analytics provides a foundation to build upon when making important clinical trial decisions.

For more information on ATTUNE Analytics, visit

About Clinical SCOREClinical SCORE provides the pharmaceutical industry with breakthrough analytics for drug development. The company's proprietary processes combine traditional market research methodologies with statistical evidence to give sponsors the detailed insights necessary to improve drug development progression. The company's research offerings include ATTUNE Analytics and ENGAGE™ Asssessment to enhance clinical operations and CRO/sponsor relationships, CLINICAL TRIAL INSIGHTS (CTI) and CTI PLUS to optimize post-clinical and commercial marketing efforts, and PARTNER OF CHOICE™ Analysis to maximize the effectiveness of medical affairs initiatives.

Media Inquiries:   Taryn Chance, MLD, MPhil (c) Director of Marketing Clinical SCORE, LLC

To view the original version on PR Newswire, visit:




You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
European Medicines Agency Validates the Marketing ...
One-Third of Stroke Patients Who Get Admitted to H...